Vascular Surgery Resident @ UC Davis | Wife | Dog mom | Opinions are my own
California
Joined July 2020
- Tweets133
- Following403
- Followers455
- Likes1.1K
KatDiLosaMD retweeted
The #VascularSurgeon when told that Doppler pulses are present.
The cardiologist when a troponin is ordered for a mechanical fall. xitter.cf/MindOfBron/status/2050…
KatDiLosaMD retweeted
Vascular surgery trainees, by and large, feel very supported to pursue parenthood! I think this really speaks to the strides we’ve made as a specialty! #SCVS2025
KatDiLosaMD retweeted
Only in her 30s, Dr. Anna Xue has already accomplished what takes years of dedication, perseverance, and skill.
She has completed medical school, residency, and a fellowship in Advanced Aortic Surgery. She has passed her written boards and is now working alongside some of the nation’s top heart surgeons including Drs. @JCoselli_MD , @DrRosengart , @MarcMoonMD.
Cardiac surgery is a demanding field, but Dr. @annaxuemd proves that women belong here too—breaking barriers, saving lives, and leading the way for the next generation of surgeons.
#WomenInMedicine #HeartSurgery #BreakingBarriers
Great opportunity to learn about vascular surgery, network, and explore opportunities!
The VAM25 scholarship application site is now open! The scholarship supports aspiring vascular surgeons in attending VAM25. Learn more and apply by Jan. 6 at 4pm EST: ow.ly/p7ln50Um6uL
KatDiLosaMD retweeted
Meet the November PD of the Month, Yana Etkin, MD. Read more here: vascular.org/apdvs/program-d…
Such an important topic as we look to recruiting and retraining a diverse workforce. This was a true labor of love after having my own twins during training.
“Guidance to Mitigate Occupational Risks for the Pregnant Vascular Surgery Trainee”
With a more diverse workforce, we must support all.
Fantastic work by @KatDiLosa and the rest of the team to spearhead an important topic in vascular surgery training!
jvsvi.org/article/S2949-9127…
First two TAMBEs at UCD in the books and just landed in Chicago for #VAM2024– what a week! @UCDavisVascular @VascularMaximus @mhumphriesmd @LoCralle @WLGore
KatDiLosaMD retweeted
Work pain is risk factor for vascular surgery trainee burnout
Of 527 trainees, 38% reported moderate/severe pain after a full day of work w/ 73.6% using ergonomic adjustments & 67.0% used OTC meds. More women reported moderate to severe pain than men.
sciencedirect.com/science/ar… – at Chicago, IL
KatDiLosaMD retweeted
My partner had her @WellsFargo checking and savings accounts cleaned out by scammers, including a credit card cash advance to increase the balance first. Gave NO personal or security info to anyone. Bank has told us that it is her fault and they will not refund anything (1/x)
KatDiLosaMD retweeted
More data supporting the value of vascular surgeons - we are critical in supporting elective and urgent procedures across hospital service lines. Great work @YoungKimMD @ehweissler Dr Mohan and Dr Williams!! @DukeVascular #VESS24
KatDiLosaMD retweeted
HUGE congratulations to our newly appointed 49th @VESurgery President - @mhumphriesmd !!🎉👏🎉👏. Our future remains limitless as we support the next generation of vascular surgeon innovators!! So proud, inspired and excited!! #VESS24 @UCDavisVascular @UCDavisSurgery
KatDiLosaMD retweeted
The APDVS is delighted to present RPVI modules designed to enhance comprehension of vascular laboratory imaging and prepare trainees for the RPVI exam. Check it out on the APDVS YouTube channel:
youtube.com/watch?v=q6dNrFNF…
It took a village to get us here…welcome to 35 weeks with TWINS! Thankful for supportive faculty! And shoutout to the nurses who always find me a stool and put on my SCDs during cases! @mhumphriesmd @UCDavisVascular @mimmieMD @VascularMaximus @MdHedayati @homebrewingMD
So excited to be a part of this fabulous issue! @mhumphriesmd @UCDavisVascular
No better way to kick off #WomenInMedicine month than by announcing that the @avsgjournal #OriginalWorkbyWomen issue is live.
38 articles with women first and last authors🤩.
Huge shoutout to the all-women editor team who curated this special issue 👏!
annalsofvascularsurgery.com/…
KatDiLosaMD retweeted
Solution for short landing zone in #TCAR in patients who are truly not candidates for CEA. Sew 10 mm Dacron graft conduit to common carotid. Remove sheath stopper to advance the sheath several centimeters in the conduit. Now you have 15 cm landing zone.
KatDiLosaMD retweeted
There’s been a lot of negativity on #VascularTwitter towards this technique but I think it has validity…. If a patient is deemed high risk for carotid endarterectomy but appropriate for TCAR, I’d think sewing on a conduit would be less strenuous than CEA 🤷🏼♂️ #jvscitXchat
KatDiLosaMD retweeted
For everyone doing CEA and CAS, this CMS National Coverage Determination (NCD 20.7) is an important topic, and you should consider weighing in.
This proposal:
-Will expand CMS coverage to patients previously only eligible for tf-CAS in a clinical trial.
-Will expand coverage to standard surgical risk individuals
-Will remove facility standards and approval requirements
-Provides no requirement for registry participation or reporting of outcomes
A few important points to consider before we open the proverbial flood gates for tf-CAS:
-Currently, there is no level 1 evidence that supports the use of tf-CAS over CEA or TCAR or medical management in standard surgical risk patients as this would allow.
-The preponderance of existing literature demonstrates a higher 30-day stroke risk of tf-CAS over CEA (nice relatively recent review here: ejves.com/article/S1078-5884…)
-There is an ongoing NIH funded clinical trial (CREST-2; clinicaltrials.gov/study/NCT…) that would provide Level 1 evidence towards this question. Why are we making this decision before this multi-million dollar trial is complete?
-This proposal provides no requirement of ongoing monitoring of outcomes.
-There is a significant learning curve for CAS (journals.sagepub.com/doi/10.… among others), highlighting the importance of proper credentialing and following outcomes (especially for low-volume operators)
-Ultimately, there is a significant risk of increased stroke in CMS beneficiaries with this change, with no method to capture the additional potential harm to our Medicare beneficiaries. At the very least, registry participation and reporting (as has been done very successfully with TCAR) should be required so that we can follow outcomes and change course in the future, if necessary.
-We are currently learning lessons related to unfettered use of percutaneous procedures in outpatient settings. This seems to be begging for a repeat of that history, only in the world of CAS: propublica.org/article/maryl…
nytimes.com/2023/07/15/healt…
Submit your comments to CMS here:
cms.gov/medicare-coverage-da…
There are 8 days left to submit a public comment about @CMSGov proposed carotid artery stenting expansion. I just submitted my opinion - have you submitted yours?!? #DelayTheExpansion #CarotidEd @VascularSVS
cms.gov/medicare-coverage-da…
KatDiLosaMD retweeted
Stenter of a narrowed vessel…
Fixer of a clotted graft…
And I will HAVE my flow…
In this case or the next. 💪
KatDiLosaMD retweeted
Device makers have bankrolled a cottage industry of doctors and clinics that perform artery-clearing procedures that can lead to amputations, a New York Times investigation found. It targets patients with a disease rarely requiring aggressive treatments. nyti.ms/44qZFLE
ALT Headline over a photo of a woman in a wheelchair staring at the camera reads: "They Lost Their Legs. Doctors and Health Care Giants Profited." Photo by Cydni Elledge for The New York Times.
KatDiLosaMD retweeted
Front page Sunday @nytimes - doesn't get much bigger than this. #Approrpriateness in the treatment of #claudication is finally getting the public attention it deserves. 👏 @jbsgreenberg @katie_thomas @gebeloffnyt
Follow below for a short #Tweetorial on the #CMS data behind this
